GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Tax Rate %

Sun Pharma Advanced Research Co (NSE:SPARC) Tax Rate % : -0.09% (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Sun Pharma Advanced Research Co's Tax Expense for the three months ended in Dec. 2024 was ₹0.7 Mil. Sun Pharma Advanced Research Co's Pre-Tax Income for the three months ended in Dec. 2024 was ₹-794.4 Mil. Therefore, Sun Pharma Advanced Research Co's Tax Rate % for the quarter that ended in Dec. 2024 was -0.09%.

Sun Pharma Advanced Research Co Tax Rate % Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Tax Rate % Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.10

Sun Pharma Advanced Research Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.36 -0.42 -0.15 -0.09

Sun Pharma Advanced Research Co Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Sun Pharma Advanced Research Co's Tax Rate % for the fiscal year that ended in Mar. 2024 is calculated as

Tax Rate %=Tax Expense (A: Mar. 2024 )/Pre-Tax Income (A: Mar. 2024 )
=3.82/-3868.319
=-0.10 %

Sun Pharma Advanced Research Co's Tax Rate % for the quarter that ended in Dec. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Dec. 2024 )/Pre-Tax Income (Q: Dec. 2024 )
=0.7/-794.4
=-0.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co Tax Rate % Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Tax Rate %
Comparable Companies
BOM:506690 BOM:524735 NSE:INNOVACAP BOM:524372 NSE:RPGLIFE NSE:STAR BOM:509079 BOM:512529 BOM:531599 BOM:530549 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
532872:India
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Website
https://www.sparc.life
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines